Clinical Trials: Adenocarcinoma

Birmingham : Birmingham Hematology and Oncology Associates, LLC

A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma

Birmingham : Birmingham Hematology and Oncology Associates, LLC

Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Birmingham :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Birmingham :

Study of Ruxolitinib in Pancreatic Cancer Patients

Homewood : Urology Center of Alabama

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Chandler : Ironwood Cancer and Research Center

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Chandler : GSK Investigational Site

Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone

Glendale : Arizona Center for Hematology Oncology

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Scottsdale : Mayo Clinic Arizona - Cancer Clinical Research Unit Updated

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Scottsdale : Research Site Updated

AMG 172 First in Human Study in Patients With Kidney Cancer

View More »

Scottsdale : Updated

AMG 172 First in Human Study in Patients With Kidney Cancer

Tucson : Arizona Cancer Center at University of Arizona

Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma

Fort Smith : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Hot Springs :

Study of Ruxolitinib in Pancreatic Cancer Patients

Alhambra : Central Hematology Oncology Medical Group, Inc.

A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma

Alhambra : Central Hematology Oncology Medical Group, Inc.

Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Bakersfield : Comprehensive Blood and Cancer Center

A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma

Bakersfield : Comprehensive Blood and Cancer Center

Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Bakersfield : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

View More »

Beverly Hills : Providence Health System

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Beverly Hills : GSK Investigational Site

Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone

Burbank : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Burbank :

Study of Ruxolitinib in Pancreatic Cancer Patients

Duarte : City Of Hope National Medical Center

A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas

Duarte : City of Hope Cancer Center

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

Fresno : Cancer Care Associates of Fresno Medical Group, Inc.

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Fresno : Cancer Care Associates of Fresno Medical Group, Inc.

A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma

Fullerton : Saint Jude Heritage Healthcare

Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Fullerton : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Gilroy : Medical Oncology Hematology

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Greenbrae : California Cancer Care, Inc.

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

La Jolla : Moores University of California San Diego Cancer Center

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

La Jolla : The Rebecca and John Moores UCSD Cancer Center

A Study of Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the Liver

La Jolla : Thornton Hospital

A Study of Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the Liver

La Jolla : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

La Jolla : UCSD Moores Cancer Center

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

La Jolla : University of California San Diego / Moores Cancer Center

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

La Verne : Wilshire Medical Oncology Group

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Long Beach : Pacific Shores Medical Group

A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma

Long Beach : Pacific Shores Medical Group

Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Los Angeles : Glendale Adventist Medical Center

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Los Angeles : Usc/Norris Comprehensive Cancer Center

A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas

Los Angeles : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Los Angeles : UCLA Community Oncology Practice

A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma

Los Angeles : UCLA Community Oncology Practice

Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Los Angeles : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Los Angeles : USC / Norris Comprehensive Cancer Center

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Los Angeles : Keck Hospital of USC

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Los Angeles : LAC + USC Medical Center

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Los Angeles :

Study of Ruxolitinib in Pancreatic Cancer Patients

Montebello : Clinical Trials and Research Associates, Inc.

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Oceanside : North Country Oncology-Hematology

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Palm Springs : Desert Comprehensive Cancer Center

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

Rancho Mirage : Desert Hematology Oncology Medical Group, Inc.

Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Rancho Mirage : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Redlands : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Redondo Beach : Cancer Care Associates Medical Group

Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Redondo Beach : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

San Diego : UCSD Medical Center

A Study of Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the Liver

San Francisco : Pacific Hematology Oncology Associates

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

San Francisco : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

San Francisco : UCSF Helen Diller Family Comprehensive Cancer Center

FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma

San Francisco : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Santa Maria : Central Coast Medical Oncology

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Santa Maria : Central Coast Medical Oncology Corp

Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Santa Maria : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Santa Monica :

Study of Ruxolitinib in Pancreatic Cancer Patients

Aurora : University of Colorado Cancer Center

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

Aurora : Pfizer Investigational Site

PF-00299804 As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung

Aurora : University of Colorado at Denver and Health Science Center

Trial of Preoperative Capecitabine Oxaliplatin Cetuximab & Radiation Therapy for Locally Advanced Esophageal Adenocarcinoma

Denver : Rocky Mountain Cancer Centers, LLP

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Denver : The Urology Center of Colorado

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

View More »

Denver :

Study of Ruxolitinib in Pancreatic Cancer Patients

Denver : Rocky Mountain Cancer Center

Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma

Grand Junction : Saint Mary's Regional Cancer Center

A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma

Grand Junction : Saint Mary's Regional Cancer Center

Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

New Haven : Yale Cancer Center

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

Stamford : Hematology Oncology Associates, P.C.

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Stamford : Medical Oncology Hematology, Stamford Hospital

MLN8237 in Adults With Nonhematological Malignancies, Followed by MLN8237 in Lung, Breast, Head and Neck or Gastroesophageal Malignancies

Stamford :

Study of Ruxolitinib in Pancreatic Cancer Patients

Newark : Christiana Care Health Services Helen Graham Cancer Center

A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies.

Boca Raton : Center for Hematology-Oncology

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Boynton Beach :

Study of Ruxolitinib in Pancreatic Cancer Patients

Boynton Beach : Palm Beach Institute / Collaborative Research Group

Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma

Deerfield Beach : Medical Specialists of the Palm Beaches

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Fort Lauderdale : Broward General Medical Center

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

View More »

Fort Myers : Florida Cancer Specialists

Study of Pazopanib and Doxil in Patients With Advanced Relapsed Platinum-Sensitive or Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Adenocarcinoma

Ft. Myers :

Study of Ruxolitinib in Pancreatic Cancer Patients

Jacksonville : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Lake City : Cancer Care of North Florida

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Miami : University of Miami

Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma

Miami Beach : Mount Sinai Comprehensive Cancer Center

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

Miramar : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

New Port Richey : Florida Cancer Institute-New Hope

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Ocala : Ocala Oncology Center, PL

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Orlando : MD Anderson Cancer Center-Orlando

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Ormond Beach : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Pembroke Pines : Memorial Cancer Institute

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

St. Petersburg :

Study of Ruxolitinib in Pancreatic Cancer Patients

Tampa : H. Lee Moffitt Cancer Center and Research Institute

Pre-operative 5-Fluorouracil (5-FU) and Sorafenib With External Radiation in Locally Advanced Rectal Cancer

Atlanta : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Atlanta : Georgia Cancer Specialists, P.C.

A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma

Atlanta : Peachtree Hematology Oncology Consultants, PC

Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Atlanta : Emory University

Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors

Atlanta : Piedmont Hospital Research Institute

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

View More »

Atlanta : Piedmont Healthcare Research Institute (PHRI)

Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma

Augusta : GSK Investigational Site

Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone

Lawrenceville : Suburban Hematology Oncology Associates, PC

Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Honolulu : University of Hawaii Cancer Center

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

Arllington Heights :

Study of Ruxolitinib in Pancreatic Cancer Patients

Centralia : University Hematology Oncology, Inc.

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Chicago : University of Chicago Medical Center

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Chicago : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Chicago : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

View More »

Gurnee : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Harvey : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Highland Park : GSK Investigational Site

Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone

Maryville : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Quincy : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Skokie : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Zion : Cancer Treatment Centers of America (CTCA-Midwestern)

Trial of Autologous, Hapten-Modified Vaccine, OVAX, in Patients With Relapsed Stage III or IV Ovarian Cancer

Evansville : Deaconess Clinic Downtown

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Indianapolis : Indiana University Simon Cancer Center

Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Indianapolis :

Study of Ruxolitinib in Pancreatic Cancer Patients

Munster : The Community Hospital

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

South Bend : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

View More »

Terre Haute : Providence Medical Group

Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Ames : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Sioux City :

Study of Ruxolitinib in Pancreatic Cancer Patients

Westwood : University of Kansas Cancer Center

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

Hazard : Kentucky Cancer Center

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Lexington : Baptist Health System, Inc.

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Louisville : Norton Cancer Institute Research Program

Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma

Alexandria : Christus Saint Frances, Cabrini Hospital, Cabrini Cancer Center

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Baton Rouge : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Metairie : Hematology and Oncology Specialists, LLC

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

New Orleans : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Shreveport : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital Updated

Cancer Vaccines CRS-207 and GVAX Pancreas for Metastatic Pancreatic Adenocarcinoma

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Gemcitabine in Combination With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Baltimore : Johns Hopkins Oncology Center

Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma

View More »

Bethesda : National Cancer Institute

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Bethesda : National Cancer Institute Updated

Cancer Vaccines CRS-207 and GVAX Pancreas for Metastatic Pancreatic Adenocarcinoma

Bethesda : Pfizer Investigational Site

PF-00299804 As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung

Bethesda : Center for Cancer and Blood Disorders

Study of Pazopanib and Doxil in Patients With Advanced Relapsed Platinum-Sensitive or Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Adenocarcinoma

Columbia : Maryland Oncology Hematology, P.A.

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Boston : GSK Investigational Site

Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone

Boston : Novartis Investigative Site

Dose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer Patients

Boston : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Boston : Pfizer Investigational Site

PF-00299804 As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung

Boston : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

View More »

Boston : Massachusetts General Hospital (MGH)

Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma

Pittsfield : Berkshire Hematology Oncology, PC

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Worcester : UMASS Medical School

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

Worcester :

Study of Ruxolitinib in Pancreatic Cancer Patients

Ann Arbor :

Study of Ruxolitinib in Pancreatic Cancer Patients

Detroit : GSK Investigational Site

Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone

Detroit : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Detroit : Karmanos Cancer Institute

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

Detroit :

Study of Ruxolitinib in Pancreatic Cancer Patients

View More »

Farmington Hills : Detroit Clinical Research Center

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Grand Rapids : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Kalamazoo : West Michigan Cancer Center

A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma

Kalamazoo : West Michigan Cancer Center

Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Minneapolis :

Study of Ruxolitinib in Pancreatic Cancer Patients

Rochester : Mayo Clinic Updated

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Tupelo : Hematology and Oncology Associates at BridgePoint

A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma

Tupelo : Hematology and Oncology Associates at BridgePoint

Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Columbia : GSK Investigational Site

Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone

Columbia :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Saint Louis : Research Site Updated

AMG 172 First in Human Study in Patients With Kidney Cancer

St Louis : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

St. Louis : Washington University School of Medicine Updated

Cancer Vaccines CRS-207 and GVAX Pancreas for Metastatic Pancreatic Adenocarcinoma

Billings : GSK Investigational Site

Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone

Billings : Billings Clinic Cancer Center

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

Missoula : Montana Cancer Institute Foundation c/o Montana Cancer Specialists

A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma

Lincoln : Southeast Nebraska Cancer Center

Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Omaha : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Omaha : Nebraska Cancer Specialists, Methodist Estabrook Cancer Center

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

Henderson : Comprehensive Cancer Centers of Nevada

A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma

Henderson : Comprehensive Cancer Centers of Nevada

Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Las Vegas : Comprehensive Cancer Centers of Nevada

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Basking Ridge : Memoral Sloan Kettering Cancer Center

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

East Orange : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Englewood : Englewood Hospital and Medical Center

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Albuquerque : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Bronx : Einstein-Montefiore Institute for Clinical & Translational Research Updated New

A Phase 2 Study of REOLYSIN in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma

View More »

Albany : Community Care Physicians, PC

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Albany : NYOH Albany Cancer Center at Patroon Creek

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Buffalo : Roswell Park Cancer Institute

A Study of Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile Ducts

Buffalo : Roswell Park Cancer Institute

Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors or Advanced Pancreatic Cancer

Buffalo : Roswell Park Cancer Institute

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

Commack : Memorial Sloan-Kettering Cancer Center @ Suffolk

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

Jamaica : Queens Hospital Center

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Jamaica : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Jamaica : Queens Cancer Center of Queens Hospital

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

Lake Success :

Study of Ruxolitinib in Pancreatic Cancer Patients

Mew York : Beth Israel Comprehensive Cancer Center

Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Mineola : Winthrop University Hospital Updated

Efficacy and Safety of BC-819 and Gemcitabine in Patients With Locally Advanced Pancreatic Adenocarcinoma

New Hyde Park : Long Island Jewish Medical Center

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

New York : Montefiore Medical Center

A Study of REOLYSIN® in Combination With Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma

New York : Beth Israel Comprehensive Cancer Center

A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma

New York : Herbert Irving Comprehensive Cancer Center of Columbia University Updated

Cancer Vaccines CRS-207 and GVAX Pancreas for Metastatic Pancreatic Adenocarcinoma

New York : Memorial Sloan Kettering Cancer Center

Degarelix Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate Cancer

New York : New York University Langone Medical Center

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

New York : Pfizer Investigational Site

PF-00299804 As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung

New York : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

New York : Memorial Sloan-Kettering Cancer Center 1275 York Avenue

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

New York : Weill Medical College of Cornell University

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

New York : Memorial Sloan-Kettering Cancer Center

Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma

Poughkeepsie : Premier Medical Group of the Hudson Valley

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Rochester : University of Rochester, James P. Wilmot Cancer Center

A Study of Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile Ducts

Rockville Centre : Memorial Sloan-Kettering at Mercy Medical Center

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

Sleepy Hollow : Memoral Sloan Kettering Cancer Center@Phelps Memorial Hospital

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

Syracuse : Syracuse Veterns Affairs Medical Center

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Syracuse : Research Foundation of State University of New York

Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Chapel Hill : University of North Carolina Lineberger Comprehensive Cancer Center

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

Chapel Hill : UNC - Chapel Hill

Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors

Durham : Research Site

A Study to Evaluate the Safety and Tolerability of MEDI-565 in Adults With Gastrointestinal Adenocarcinomas

Durham : Duke University Medical Center Updated

Cancer Vaccines CRS-207 and GVAX Pancreas for Metastatic Pancreatic Adenocarcinoma

Durham : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

View More »

Durham : Duke University Medical Center

Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma

Durham :

Study of Ruxolitinib in Pancreatic Cancer Patients

Hickory :

Study of Ruxolitinib in Pancreatic Cancer Patients

High Point : Emerywood Hematology and Oncology

A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma

High Point : Emerywood Hematology and Oncology

Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Raleigh : GSK Investigational Site

Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone

Winston Salem : University of Wake Forest Baptist Medical Center

Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma

Bismarck : St. Alexis Medical Center-Mid Dakota Clinic PC

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

Canton :

Study of Ruxolitinib in Pancreatic Cancer Patients

Cincinnati : University of Cincinnati Cancer Center

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

Cincinnati : Oncology Hematology Care

Study of Pazopanib and Doxil in Patients With Advanced Relapsed Platinum-Sensitive or Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Adenocarcinoma

Cleveland : University Hospital of Cleveland

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

Columbus : Ohio State University

A Study of Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile Ducts

View More »

Middletown : Signal Point Clinical Research Center, LLC

Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Oklahoma City : University of Oklahoma Health Sciences Center

Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma

Tulsa : Cancer Treatment Centers of America (CTCA-Southwestern)

Trial of Autologous, Hapten-Modified Vaccine, OVAX, in Patients With Relapsed Stage III or IV Ovarian Cancer

Bend : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Bend :

Study of Ruxolitinib in Pancreatic Cancer Patients

Eugene : Willamette Valley Cancer Institute and Research Center

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Portland : Providence Portland Medical Center Updated

Cancer Vaccines CRS-207 and GVAX Pancreas for Metastatic Pancreatic Adenocarcinoma

Portland : Kaiser Permanente NW

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

Abington : GSK Investigational Site

Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone

Bethlehem : St. Luke's Cancer Center Associates

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Gettysburg : Gettysburg Cancer Center

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Philadelphia : Research Site

A Study to Evaluate the Safety and Tolerability of MEDI-565 in Adults With Gastrointestinal Adenocarcinomas

Philadelphia : Thomas Jefferson University

Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer

View More »

Philadelphia : Fox Chase Cancer Center

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

Philadelphia : University of Pennsylvania

Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas

Philadelphia :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Philadelphia : Cancer Treatment Centers of America (ERMC)

Trial of Autologous, Hapten-Modified Vaccine, OVAX, in Patients With Relapsed Stage III or IV Ovarian Cancer

Pittsburgh : University of Pittsburgh Cancer Institute

Phase II Study of Irinotecan and Panitumumab

Pittsburgh : University of Pittsburgh Cancer Institute

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

Pittsburgh :

Study of Ruxolitinib in Pancreatic Cancer Patients

Pittsburgh : University of Pittsburgh Cancer Institute

Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma

West Reading : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Providence : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Providence : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Charleston : Charleston Hematology Oncology Associates, PA

A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma

Charleston : Charleston Hematology Oncology Associates

Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Charleston : Medical University of South Carolina

Feasibility and Safety Study in Patients With Metastatic Pancreatic Adenocarcinoma

Charleston : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Charleston : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

View More »

Columbia : South Carolina Oncology Associates

A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma

Columbia : South Carolina Oncology Associates

Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Greenville : Gynecologic Oncology Research & Development, LLC

A Phase II Evaluation of Docetaxel and Carboplatin Followed by Tumor Volume Directed Pelvic Irradiation

Myrtle Beach : Grand Strand Urology

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Chattanooga : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Germantown :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Knoxville : Tennessee Cancer Specialists

A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma

Knoxville : Tennessee Cancer Specialists

Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Knoxville : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

View More »

Knoxville : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Knoxville :

Study of Ruxolitinib in Pancreatic Cancer Patients

Memphis : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Nashville : Tennessee Oncology, PLLC

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Nashville : Sarah Cannon Research Institute Updated

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Nashville : Vanderbilt-Ingram Cancer Center

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

Nashville : Tennessee Oncology, PLLC

Study of Pazopanib and Doxil in Patients With Advanced Relapsed Platinum-Sensitive or Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Adenocarcinoma

Abilene : GSK Investigational Site

Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone

Bedford : Texas Oncology - Bedford

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Corpus Christi : Coastal Bend Cancer Center

A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma

Dallas : Mary Crowley Cancer Research Centers - Medical City Updated

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Dallas : Mary Crowley Cancer Center

Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors

View More »

Fort Worth : Center for Cancer and Blood Disorders, PC

A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma

Fort Worth : Center for Cancer and Blood Disorders, PC

Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Fort Worth : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Galveston : University of Texas Medical Branch

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Houston : Houston Cancer Institute

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Houston : The University Of Texas Md Anderson Cancer Center

A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas

Houston : UT MD Anderson Cancer Center

Bevacizumab With Capecitabine and Oxaliplatin in Advanced Adenocarcinoma of the Small Bowel or Ampulla of Vater

Houston : UT MD Anderson Cancer Center

CAPOX in KRAS Wild-Type Advanced Adenocarcinoma of the Small Bowel or Ampulla of Vater

Houston : UT MD Anderson Cancer Center Updated

Irinotecan Plus Brivanib in Metastatic Colorectal Cancer (CRC) Enriched for Elevated Levels of Plasma FGF

Houston : MD Anderson Cancer Center

MLN8237 in Adults With Nonhematological Malignancies, Followed by MLN8237 in Lung, Breast, Head and Neck or Gastroesophageal Malignancies

Houston : UT MD Anderson Cancer Center

Prostate Conformal Cryotherapy

Lubbock : Joe Arrington Cancer Research and Treatment Center

A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma

Lubbock : Joe Arrington Cancer Research & Treatment Center Updated

Efficacy and Safety of BC-819 and Gemcitabine in Patients With Locally Advanced Pancreatic Adenocarcinoma

Lubbock : Joe Arrington Cancer Research and Treatment Center

Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Paris : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Plano : Texas Oncology - Plano East

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Plano : GSK Investigational Site

Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone

San Antonio : University of Texas Health Science Center at San Antonio

A Phase 1 Study of MLN8237 in Patients With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel Regimen

San Antonio : Cancer Therapy & Research Center at UTHSCSA

A Study of REOLYSIN® in Combination With Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma

San Antonio : Veterans Affairs at UTHSCSA

A Study of REOLYSIN® in Combination With Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma

San Antonio : Novartis Investigative Site

Clinical Study of BYM338 for the Treatment of Unintentional Weight Loss in Patients With Cancer of the Lung or the Pancreas

San Antonio : South Texas Oncology and Hematology, PA

Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

San Antonio : Urology San Antonio Research

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

San Antonio :

Study of Ruxolitinib in Pancreatic Cancer Patients

Sugar Land : Northwest Cancer Center

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Temple : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Tyler : Texas Oncology - Tyler

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Waco : Texas Oncology - Waco

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Murray : GSK Investigational Site

Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone

Salt Lake City : Novartis Investigative Site

Dose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer Patients

Salt Lake City : Huntsman Cancer Institute

MLN8237 in Adults With Nonhematological Malignancies, Followed by MLN8237 in Lung, Breast, Head and Neck or Gastroesophageal Malignancies

Charlottesville : University of Virginia Health System Updated

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Fairfax : Virginia Cancer Specialists, PC

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Fairfax : Virginia Cancer Specialists, PC

A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma

Norfolk : GSK Investigational Site

Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone

Portsmouth : Delta Hematology Oncology Associates, PC

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

View More »

Richmond : Virginia Cancer Institute

A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma

Richmond : Virginia Cancer Institute

Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Richmond :

Study of Ruxolitinib in Pancreatic Cancer Patients

Roanoke : Carilion GYN Oncology Associates

A Phase II Evaluation of Docetaxel and Carboplatin Followed by Tumor Volume Directed Pelvic Irradiation

Winchester : GSK Investigational Site

Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone

Woodbridge : GSK Investigational Site

Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone

Seattle : Virginia Mason Medical Center

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Seattle : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Seattle : Virginia Mason Medical Center Updated

Cancer Vaccines CRS-207 and GVAX Pancreas for Metastatic Pancreatic Adenocarcinoma

Seattle : Virginia Mason Medical Center

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Seattle : Swedish Medical Center Cancer Institute Updated

Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer

View More »

Spokane : Rockwood Cancer Treatment Center

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Spokane : Medical Oncology Associates, PS

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Spokane Valley : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Tacoma : GSK Investigational Site

Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone

Green Bay : Cancer Team Bellin Health

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Green Bay :

Study of Ruxolitinib in Pancreatic Cancer Patients

Milwaukee : Medical College of Wisconsin

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

Milwaukee : Medical College of Wisconsin

Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma

Bahia Blanca : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Buenos Aires : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Ciudad Autonoma de Buenos Aires : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Ciudada Autonoma : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Cordoba : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

View More »

Quilmes : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Rosario : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Rosario : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Rosario Santa Fe : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Santa Fe : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Tucuman : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Adelaide : Royal Adelaide Hospital, Cancer Centre

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Bankstown : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Bedford Park : Flinders Medical Centre, Dept. of Oncology

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Bedford Park : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Bentleigh East : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

View More »

Box Hill : Box Hill Hospital

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Brisbane : Royal Brisbane and Women's Hospital, Dept. of Medical Oncology

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Coburg : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

East Melbourne : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Elizabeth Vale : Lyell McEwin Hospital

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Footscray : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Frankston : Frankston Hospital, Oncology Day Unit

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Frankston : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Fremantle : Fremantle Hospital

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Heidelberg : 1200.123.6105 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Hobart : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Kogarah : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Kogarah : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Kurralta Park : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Kurralta Park : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Liverpool : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Melbourne : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Nedlands : 1200.123.6106 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Parkville : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Parkville : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Perth : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Richmond : Epworth Healthcare

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

South Brisbane : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

South Brisbane : 1200.123.6103 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Southport : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

St. Leonards : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Tweed Heads : The Tweed Hospital

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Wollongong : Southern Medical Day Oncology Care Centre

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Wollongong : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Woodville : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Woodville South : The Queen Elizabeth Hospital

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Woodville South : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Woolloongabba : Princess Alexandra Hospital

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Graz : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Innsbruck : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Linz : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Linz : KH Elisabethinen Linz

Concurrent Induction Chemoimmunotherapy With Epirubicine, Oxaliplatin, Capecitabine and Panitumumab in KRAs Wild-type, Resectable Type II Gastric Adenocarcinoma

Linz : AKh Linz

Concurrent Induction Chemoimmunotherapy With Epirubicine, Oxaliplatin, Capecitabine and Panitumumab in KRAs Wild-type, Resectable Type II Gastric Adenocarcinoma

View More »

Salzburg : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Salzburg : Universitätsklinik für Innere Medizin III

Concurrent Induction Chemoimmunotherapy With Epirubicine, Oxaliplatin, Capecitabine and Panitumumab in KRAs Wild-type, Resectable Type II Gastric Adenocarcinoma

Salzburg : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Steyr : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Steyr : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Wels : Klinikum Kreuzschwestern Wels GmbH

Concurrent Induction Chemoimmunotherapy With Epirubicine, Oxaliplatin, Capecitabine and Panitumumab in KRAs Wild-type, Resectable Type II Gastric Adenocarcinoma

Wien : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Wien : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Zams : St. Vinzenz Krankenhaus Betriebs GmbH

Concurrent Induction Chemoimmunotherapy With Epirubicine, Oxaliplatin, Capecitabine and Panitumumab in KRAs Wild-type, Resectable Type II Gastric Adenocarcinoma

Bonheiden : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Brugge : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Brussels : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Brussels : Novartis Investigative Site

RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe

Bruxelles : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

View More »

Charleroi : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Edegem : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Edegem : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Gent : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Gent : Novartis Investigative Site

RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe

Jette : AZ VUB

First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene

Leuven : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Leuven : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Libramont : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Sarajevo : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Barretos : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Belo Horizonte : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Belo Horizonte : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Brasilia : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Caxias do Sul : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

View More »

Curitba : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Curitiba : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Fortaleza : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Gavea : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Goiania : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Ijui : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

ItajaÃ- : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Itajai : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Lajeados : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Londrina : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Passo Fundo : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Porto Alegre : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Porto Alegre : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Porto Alegre : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Ribeirao Preto : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Rio de Janeiro : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

São Paulo : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Salvador : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Salvador : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Santo Andre : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Sao Jose Rio Preto : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Sao Paulo : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Sao Paulo : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Sorocaba : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Gabrovo :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Haskovo : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Pleven : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Plovidv :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Sofia : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

View More »

Sofia :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Varna : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Veliko Tarnovo :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Barrie : Royal Victoria Hospital

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Brampton : GSK Investigational Site

Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone

Edmonton : Cross Cancer Institute

First Line Study of Irinotecan, Capecitabine and Oxaliplatin in Metastatic Gastric or Gastroesophageal Cancer.

Edmonton : 1200.123.1005 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Halifax : GSK Investigational Site

Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone

View More »

Kitchener : Grand River Regional Cancer Centre

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Montreal : Jewish General Hospital

Adjuvant Androgen Suppression Plus Radiation Therapy for High-Risk Localized Adenocarcinoma Prostate

Montreal : Montreal General Hospital

Adjuvant Androgen Suppression Plus Radiation Therapy for High-Risk Localized Adenocarcinoma Prostate

Montreal : 1200.123.1001 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Montreal : 1200.123.1007 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Montréal : Jewish General Hospital

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Oshawa : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Oshawa : 1200.123.1006 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Ottawa : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Quebec : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Rimouski : GSK Investigational Site

Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone

Sherbrooke : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Surrey : 1200.123.1004 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Toronto : Princess Margaret Hospital

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Toronto : Local Institution

A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas

Toronto : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Vancouver : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Vancouver : 1200.123.1002 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Concepcion : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

La Serena : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Providencia : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Santiago : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Vina del Mar : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Beijing : Department of GI Oncology, Peking University, School of Oncology

Paclitaxel Plus Capecitabine With Capecitabine Maintenance Treatment in Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction

Cali : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Monteria : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Osijek : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Pula : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Slavonski Brod : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Zagreb : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Brno : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Brno : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Hradec Kralove : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Hradec Kralove : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Liberec : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

View More »

Olomouc : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Pardubice : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Prague : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Praha 2 : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Praha 2 : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Praha 5 : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Pribram : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Aalborg : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Herlev : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Odense : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Alexandria : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Cairo : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Tallinn : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

HUS : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Lahti : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Tampere : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Turku : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Bayonne : 1200.123.3307 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Besançon Cedex : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Besancon Cedex : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Brest cedex : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Caen Cedex 05 : 1200.123.3305 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

View More »

Clermont Ferrand Cedex 1 : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Clermont-Ferrand : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Limoges Cedex : 1200.123.3308 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Lyon Cedex 08 : 1200.123.3301 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Marseille : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Montbeliard : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Montpellier : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Paris : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Paris : 1200.123.3303 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Pessac Cedex : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Saint Etienne : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Saint Herblain Cedex : 1200.123.3302 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Saint-Pierre Cedex -La Réunion : 1200.123.3306 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Villejuif : Research Site Updated

AMG 172 First in Human Study in Patients With Kidney Cancer

Berlin : HELIOS Klinikum Emil von Behring

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Berlin : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Berlin : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Bielefeld : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Bonn : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

View More »

Braunschweig : Prof. Dr. F. Lordick

Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric Adenocarcinomas

Dresden : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Dresden : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Essen : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Essen : 1200.123.4901 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Frankfurt : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Frankfurt am Main : Krankenhaus Nordwest GmbH

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Frankfurt am Main : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Freiburg : University Hospital Freiburg Gynecological Clinic

Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer

Gauting : Asklepios Fachkliniken München-Gauting

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Halle : Städtisches Krankenhaus Martha-Maria Halle Dölau gGmbH

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Halle : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Halle (Saale) : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Hamburg : Asklepios Klinik Harburg

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Hamburg : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Hamburg : 1200.123.4904 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Hamburg : University Hospital Hamburg-Eppendorf

Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer

Hannover : Novartis Investigative Site

RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe

Heidelberg : Universitätsklinikum Heidelberg

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Heidelberg : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Kassel : Hospital Kassel

Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer

Leipzig : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Löwenstein : Klinik Löwenstein gGmbH

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Münster : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Mainz : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Mainz : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Mainz : 1200.123.4902 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Mannheim : Tagestherapiezentrum am ITM & III. Medizinische Klinik Universitätsmedizin Mannheim

Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or Stomach

Mannheim : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Marburg : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Minden : Johannes-Wesling-Klinikum Minden

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Muenchen : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Münster : 1200.123.4903 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Recklinghausen : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Schweinfurt : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Tuebingen : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Ulm : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Villingen-Schwenningen : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Würzburg : University Hospital Würzburg

Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer

Athens : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Heraklion : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Patra : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Thessaloniki : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Guatemala City : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Hong Kong : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Kowloon : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Sha Tin : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Tuen Mun : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Budapest : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Budapest : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Budapest : Semmelweis University; Clinic for Pulmonology

Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung

Debrecen : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Debrecen : University of Debrecen Medical and Health Science Center, Clinic of Pulmonology

Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung

View More »

Deszk : Hospital for Thoracic Diseases of Csongrad County Local Government

Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung

Gyor : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Gyula : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Kaposvar : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Pecs : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Szekesfehervar : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Bangalore : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Chennai : Lifeline Multispeciality Hospitals

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

Chennai : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Chennai : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Chennai : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

View More »

Hyderabad : Basavatarakam Indo-American Cancer Hospital

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

Hyderabad : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Hyderabad : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Kolkata : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Kolkata : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Kolkata : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Mumbai : Jaslok Hospital & Research Centre

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

Mumbai : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Nashik : Shatabdi Superspeciality Hospital

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

Pune : Ruby Hall Clinic

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

Pune : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Pune : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Thiruvananthapuram : Regional Cancer Center

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

Thiruvananthapuram : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

West Bengal : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Jakarta : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Sumatera Utara : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

West Java : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Beer Sheva : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Haifa : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Haifa : Carmel Medical Center Updated

Efficacy and Safety of BC-819 and Gemcitabine in Patients With Locally Advanced Pancreatic Adenocarcinoma

Haifa : Rambam Medical Center Updated

Efficacy and Safety of BC-819 and Gemcitabine in Patients With Locally Advanced Pancreatic Adenocarcinoma

Haifa : Rambam medical Center

Immunochemotherapy for Metastatic Renal Cell Carcinoma

View More »

Holon : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Jerusalem : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Jerusalem : Hadassah Medical Organization Updated

Efficacy and Safety of BC-819 and Gemcitabine in Patients With Locally Advanced Pancreatic Adenocarcinoma

Jerusalem : Hadassah Medical Organization

Phase I - Escalating Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Locally Advanced Adenocarcinoma of the Pancreas, and a Single Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Operable Adenocarcinoma of the Pancreas

Kfar Saba : Meir Medical Center Updated

Efficacy and Safety of BC-819 and Gemcitabine in Patients With Locally Advanced Pancreatic Adenocarcinoma

Nahariya : Galil Maaravi Updated

Efficacy and Safety of BC-819 and Gemcitabine in Patients With Locally Advanced Pancreatic Adenocarcinoma

Petah Tikva : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Ramat Gan : Sheba Medical Center

Phase I - Escalating Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Locally Advanced Adenocarcinoma of the Pancreas, and a Single Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Operable Adenocarcinoma of the Pancreas

Tel Aviv : Tel Aviv Medical Center Updated

Efficacy and Safety of BC-819 and Gemcitabine in Patients With Locally Advanced Pancreatic Adenocarcinoma

Tel Hashomer : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Ancona : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Aviano : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Bari : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Bergamo : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Brescia : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

View More »

Catania : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Cremona : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Genova : Istituto Nazionale per la Ricerca sul Cancro

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Genova : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Genova : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Lido di Camaiore : Ospedale Unico Versilia

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Lido di Camaiore : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Lucca : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Meldola : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Messina : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Milano : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Mirano : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Napoli : A.O. Seconda Università degli Studi di Napoli

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Napoli : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Orbassano : Azienda Ospedaliero-Univesitaria "San Luigi Gonzaga"

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Padova : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Pisa : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Potenza : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Rimini : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

San Giovanni Rotondo (FG) : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Torino : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Udine : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Bunkyo-ku : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Chiba : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Chikusa : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Chuo-ku : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Fukuoka : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

View More »

Hidaka : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Higashinari-Ku : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Kashiwa : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Kashiwa : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Kitaadachi-gun : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Kochi : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Koto-ku : Pfizer Investigational Site

PF-00299804 As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung

Matsuyama : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Mitaka : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Mitaka-city : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Nagoya : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Nagoya : Pfizer Investigational Site

PF-00299804 As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung

Nagoya-city : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Osaka : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Osaka-Sayama : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Osaka-shi : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Sapporo : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Shimotsuke : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Sunto-gun : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Sunto-gun : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Takatsuki : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Tokyo : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Tokyo : MSD K.K.

V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110)

Utsunomiya : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Yokohama-city : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Yufu-shi : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Cheonju-si : 1200.123.8203 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Incheon : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Incheon : 1200.123.8204 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Seongnam-si : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Seoul : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

View More »

Seoul : Catholic University, Gangnam St. Mary's Hospital

Effects of Oral Rabeprazole on the Prevention of Ulcer Bleeding Following Endoscopic Mucosal Resection

Seoul : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Seoul : 1200.123.8201 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Seoul : 1200.123.8205 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Seoul : 1200.123.8202 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Seoul : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Songpa-gu : Asan Medical Center

Trastuzumab in Combination With Capecitabine and Oxaliplatin(XELOX) in Patients With Advanced Gastric Cancer(AGC)

Suwon : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Suwon-City : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Beirut : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Kaunas : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Kaunas : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Klaipeda : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Vilnius : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Kelantan : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Pulau Pinang : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Floriana : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Aguascelientes : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Chihuahua : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Cuauhtemoc : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Juchitan : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Morelia : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Amsterdam : Local Institution

A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas

Amsterdam : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Eindhoven : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Groningen : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Leiden : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Oslo : 1200.123.4701 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Trondheim : 1200.123.4702 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Cebu City : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Pasig City : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Brzozow : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Bydgoszcz : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Elblag :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Gdansk : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Gdansk : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

View More »

Konin : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Krakow : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Lodz : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Lodz : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Lublin : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Olsztyn : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Otwock : Novartis Investigative Site

RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe

Poznan : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Poznan : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Szczecin : Specjalistyczny Szpital im. Alfreda Sokolowskiego

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Szczecin :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Torun : Wojewódzki Szpital Zespolony im. L. Rydygiera w Toruniu Szpital Dzieciecy

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Torun :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Warsaw :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Warszawa : Centrum Onkologii - Instytut im. M. Sklodowskiej-Curie w Warszawie

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Warszawa : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Warszawa : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Barreiro : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Lisboa : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Porto : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Baia Mare : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Brasov :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Bucharest :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Bucuresti : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Cluj Napoca : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

View More »

Cluj Napoca :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Cluj Napoca : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Cluj-Napoca : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Craiova :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Iasi : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Sibiu : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Suceava : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Targu Mures : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Timisoara :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Arkangelsk :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Chelyabinsk : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Chelyabinsk :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Chelyabinsk : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Ekaterinburg :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

View More »

Ivanovo : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Kazan : Republican Clinical Oncologic Dispensary of Ministry of health of Republic Tatarstan

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Krasnodar : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Krasnodar :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Krasnodar Krai :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Kursk :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Kursk : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Moscow : Cancer Research Center n.a. N.N. Blokhin

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Moscow : City Oncology Hospital # 62

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Moscow : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Moscow : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Moscow :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Moscow : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Novosibirsk :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Omsk :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Perm : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Perm : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Pyatigorsk : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Saint Petersburg : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Saint Petersburg :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Samara : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

St. Petersburg :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

St. Petersburg : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Stavropol :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Stavropol Krai :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Tambov :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Ufa : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Voronezh :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Yaroslavl :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Belgrade : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Sremska Kamenica : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Singapore : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Singapore : 1200.123.6501 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Bardejov : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Bratislava : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Kosice : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Nitra : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Poprad : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Ljubljana : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

A Coruña : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Avila : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Badalona : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Barcelona : Hospital General Vall d'Hebron, Barcelona

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Barcelona : Hospital Clinic i Provincial de Barcelona

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

View More »

Barcelona : Hospital Germans Trías i Pujol

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Barcelona : Novartis Investigative Site

Dose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer Patients

Barcelona : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Barcelona : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Barcelona : ACROSS

XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma

Burgos : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Elche : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Elche : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Jerez de la Frontera : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

La Coruna : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

La Coruña : Centro Oncológico de Galícia

Efficacy and Safety of Panitumumab Combined With Docetaxel and Cisplatin as a First-line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Madrid : Fundación Jiménez Díaz

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Madrid : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Madrid : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Madrid : 1200.123.3402 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Madrid : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Majadahonda : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Malaga : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Malaga : 1200.123.3404 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Málaga : Hospital Regional Carlos Haya

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Palma De Mallorca : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Sabadell : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Santander : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Santander : 1200.123.3403 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Santander : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Sevilla : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Sevilla : 1200.123.3401 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Eskilstuna : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Linköping : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Linköping : 1200.123.4602 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Stockholm : Dept. of Clinical Science, Intervention and Technology, Div. of surgery, Karolinska University Hospital, Huddinge

AXP107-11 in Combination With Standard Gemcitabine (Gemzar® ) Therapy for Treatment in Patients With Pancreatic Cancer

Stockholm : 1200.123.4604 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

View More »

Uppsala : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Basel : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Geneva : Please call/email Central Contact for Study Location Information

Trial of Gemcitabine With or Without MSC1936369B in Pancreatic Cancer

Geneva 14 : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Winterthur : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Changhua : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Gueishan Township : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Kaohsiung : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Liouying/Tainan : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Niaosong Township : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

View More »

Taichung : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Taichung County : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Tainan : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Taipei : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Taipei : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Taipei City : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Bangkok : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Adana : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Gaziantep : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Istanbul : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Izmir : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Chernihiv :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Dnipropetrovsk :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Donetsk :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Kharkiv :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Kherson :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

View More »

Sumy :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Uzhorod :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Zaporiahya :

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Aberdeen : 1200.123.4401 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Bebington Wirral : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Belfast : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Birmingham : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Birmingham : 1200.123.4406 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

View More »

Cambridge : Cambridge University Hospitals NHS Foundation Trust

Hedgehog Inhibition for Pancreatic Ductal Adenocarcinoma (PDAC) in the Preoperative Setting (HIPPoS)

Cottingham : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Guildford : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Guildford : 1200.123.4405 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Leicester : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Liverpool : Novartis Investigative Site

Dose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer Patients

London : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Manchester : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Northampton : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Sutton : ImClone Investigational Site

A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma

Wolverhampton : ImClone Investigational Site

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma

Washington : Research Site

A Study to Evaluate the Safety and Tolerability of MEDI-565 in Adults With Gastrointestinal Adenocarcinomas

Washington : Georgetown University

Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma